Hi again Chantelle.
Looking at the time of your last post, I'm obviously not the only insomniac on here. π
It's nice to see that two of our ladies have already responded to you, and given a partners view on things. Their input is so valuable.
You were correct in bringing Dave's heart problems to the attention of those planning his prostrate treatment. It is very common for urologists and oncologists to liaise with cardiologists when deciding the best way forward.
With regards to ADT treatment:
In an individual patient, the benefits of ADT should be balanced against the risk, and patients who require ADT should have risk factors for cardiovascular disease optimized. There is some evidence to suggest that more contemporary methods of delivering ADT may reduce cardiovascular risk.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4516188/
It concludes:
It is clear that overall, the use of ADT in the treatment of prostate cancer is associated with an increased risk of cardiovascular complications. However, for the most part the excess risk is modest though significant, and must be weighed against the equally clear benefits of ADT in appropriate patients. In the future, better identification of patients at risk – particularly those with a previous history of myocardial infarction or CHF – and perhaps more tailoring of the form and duration of ADT in an individual patient, might ameliorate the risk. However, awareness and management of the risks of cardiovascular complications must not result in the under-use of ADT.
In the HERO trail that Wife-of-YM mentioned, Relugolix seemed to be the best ADT for those on cardiac medications.
https://pubmed.ncbi.nlm.nih.gov/37713020/
Relugolix suppressed testosterone and was generally well tolerated when given with concomitant CV agents.
As I said earlier, due to my ischemic heart disease, the surgeon and aneathetist were very reluctant to give the all clear for RARP. It seemed, whenever they got the slightest whiff of a heart problem, they started to push me to radiotherapy. Obviously they don't want the risk of patients 'dying on the table', it doesn't look good on their CVs. π
However, I dreaded the thought of 35 hospital visits to get 'zapped'. I wanted treatment confined to just one overnight stay and desperately wanted surgery. I contacted my cardiologist who very promptly passed me fit enough for surgery.
Ironically, in my case, although I sailed through RARP, as if to prove their concerns correct, I had a heart attack two months later. π
I ended up on a cardiology ward for 3 weeks until they drilled an artery clear and stented me up. During this time, I was having to deal with quite bad side effects of prostate surgery. I was leaking like a sieve but couldn't get to the loo, as I was plugged into a heart monitor. It was a dreadful.
It did, however, put my cancer fears into perspective. The thought of having another cardiac arrest was and still is much more frightening than PCa. π
I don't know if Dave's heart condition totally rules out surgery? If not, it might be an idea to see if open surgery rather than RARP could be considered?
Open surgery exerts much less pressure on the heart. In RARP you are positioned with your head much lower than your feet (Trendelenburg position) and your abdomen is gas inflated, also you're usually aneathetised longer. All factors that raise heart pressure.
The outcomes of open and RARP are similar. However, open surgery has some disadvantages, bigger incision scar, chance of greater blood loss and longer recovery in hospital. Nothing is ever simple with this disease.π
Anyway, big hugs to you both.
Edited by member 25 Oct 2026 at 07:58
| Reason: Add link